Panagiotis Papathanasopoulos Selected Research

Panagiotis Papathanasopoulos Research Topics

Disease

6	Multiple Sclerosis 01/2018 - 01/2008
5	Relapsing-Remitting Multiple Sclerosis 01/2017 - 10/2010
2	Polyneuropathies (Polyneuropathy) 03/2015 - 09/2014
2	Demyelinating Diseases (Demyelinating Disease) 01/2015 - 01/2010
2	Stroke (Strokes) 10/2011 - 10/2010
2	Ischemic Stroke 01/2011 - 10/2010
2	Parkinson Disease (Parkinson's Disease) 06/2010 - 11/2009
1	Chronic Progressive Multiple Sclerosis 01/2020
1	Fatigue 01/2020
1	Cognitive Dysfunction 01/2017
1	Paralysis (Palsy) 10/2016
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2016
1	Inflammation (Inflammations) 10/2016
1	Atrophy 09/2015
1	Muscle Weakness 03/2015
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 03/2015
1	Nervous System Diseases (Neurological Disorders) 01/2015
1	Disease Progression 01/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2014
1	Hypesthesia (Numbness) 09/2014
1	Pain (Aches) 03/2014
1	Leiomyoma (Uterine Fibroids) 03/2014
1	Intracranial Hypertension 12/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2011
1	Seizures (Absence Seizure) 11/2011
1	Partial Epilepsies (Epilepsy, Partial) 11/2011
1	Vascular Diseases (Vascular Disease) 10/2011
1	Lymphocytosis 10/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2010
1	Renal Insufficiency (Renal Failure) 01/2010
1	Opioid-Related Disorders (Opiate Addiction) 10/2009
1	Substance-Related Disorders (Drug Abuse) 10/2009
1	Reperfusion Injury 09/2009
1	Spinal Cord Ischemia 09/2009
1	Ischemia 09/2009
1	Myasthenia Gravis 01/2007
1	Thymoma (Thymic Carcinoma) 01/2007

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2015 - 12/2008
2	Natalizumab (Tysabri)FDA Link 01/2016 - 10/2010
2	LigandsIBA 08/2015 - 12/2008
2	Peptides (Polypeptides)IBA 08/2015 - 12/2008
1	Dehydroepiandrosterone (DHEA)IBA 10/2016
1	NeurosteroidsIBA 10/2016
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016
1	nitazoxanide (NTZ)FDA Link 01/2016
1	Proteins (Proteins, Gene)FDA Link 03/2015
1	GangliosidesIBA 03/2015
1	Prednisolone (Predate)FDA LinkGeneric 03/2015
1	AntibodiesIBA 03/2015
1	SteroidsIBA 03/2015
1	AntigensIBA 01/2015
1	Interleukin-4 (Interleukin 4)IBA 01/2015
1	Immunoglobulin G (IgG)IBA 01/2015
1	Acitretin FDA Link 09/2014
1	Doxazosin (Cardura)FDA LinkGeneric 03/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Rituximab (Mabthera)FDA Link 12/2011
1	Pregabalin (Lyrica)FDA Link 11/2011
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2011
1	AdiponectinIBA 10/2010
1	Dopamine (Intropin)FDA LinkGeneric 06/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2010
1	Methadone (Dolophine)FDA LinkGeneric 10/2009
1	Heroin (Diamorphine)IBA 10/2009
1	Buprenorphine (Subutex)FDA LinkGeneric 10/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2009
1	triphosphoric acid (triphosphate)IBA 09/2009
1	Amifostine (Ethyol)FDA LinkGeneric 09/2009
1	Oxygen (Dioxygen)IBA 09/2009
1	Free Radical ScavengersIBA 09/2009
1	EpitopesIBA 12/2008
1	Myelin Basic ProteinIBA 12/2008
1	CannabinoidsIBA 01/2008
1	EnzymesIBA 01/2007
1	Caspase 3 (Caspase-3)IBA 01/2007

Therapy/Procedure

4	Therapeutics 01/2018 - 01/2008
2	Cognitive Training 01/2020 - 01/2017
1	Neurological Rehabilitation 01/2020
1	Transcranial Magnetic Stimulation 01/2018
1	Immunotherapy 08/2015
1	Oral Administration 09/2014
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2010
1	Renal Dialysis (Hemodialysis) 01/2010
1	Deep Brain Stimulation 11/2009
1	Catheters 09/2009
1	Thymectomy 01/2007